DK1107981T3 - Syntese af ringmodificerede, cykliske peptidanaloger - Google Patents

Syntese af ringmodificerede, cykliske peptidanaloger

Info

Publication number
DK1107981T3
DK1107981T3 DK99942321T DK99942321T DK1107981T3 DK 1107981 T3 DK1107981 T3 DK 1107981T3 DK 99942321 T DK99942321 T DK 99942321T DK 99942321 T DK99942321 T DK 99942321T DK 1107981 T3 DK1107981 T3 DK 1107981T3
Authority
DK
Denmark
Prior art keywords
ring
cyclic peptide
new
synthesis
amino acid
Prior art date
Application number
DK99942321T
Other languages
Danish (da)
English (en)
Inventor
Peter Stanley Borromeo
Jeffrey Daniel Cohen
George Stuart Gregory
Stacy Kay Henle
Stephen Andrew Hitchcock
Louis Nickolaus Jungheim
Daniel Ray Mayhugh
Timothy Alan Shepherd
William Wilson Turner Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1107981T3 publication Critical patent/DK1107981T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK99942321T 1998-08-20 1999-08-18 Syntese af ringmodificerede, cykliske peptidanaloger DK1107981T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9722898P 1998-08-20 1998-08-20
PCT/US1999/018908 WO2000011023A2 (en) 1998-08-20 1999-08-18 Ring modified cyclic peptide analogs

Publications (1)

Publication Number Publication Date
DK1107981T3 true DK1107981T3 (da) 2005-05-30

Family

ID=22262272

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99942321T DK1107981T3 (da) 1998-08-20 1999-08-18 Syntese af ringmodificerede, cykliske peptidanaloger

Country Status (11)

Country Link
US (2) US6653281B1 (de)
EP (1) EP1107981B1 (de)
JP (1) JP2002528388A (de)
AT (1) ATE287899T1 (de)
AU (1) AU765660B2 (de)
CA (1) CA2340676A1 (de)
DE (1) DE69923460T2 (de)
DK (1) DK1107981T3 (de)
ES (1) ES2233070T3 (de)
PT (1) PT1107981E (de)
WO (1) WO2000011023A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743777B1 (en) * 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
EP1107981B1 (de) 1998-08-20 2005-01-26 Eli Lilly & Company Verfahren zur herstellung von ring-modifizierten zyklischen peptidanalogen
AU766091B2 (en) 1998-12-09 2003-10-09 Eli Lilly And Company Purification of echinocandin cyclopeptide compounds
KR20020002476A (ko) 1999-03-03 2002-01-09 피터 지. 스트링거 결정질 에키노칸딘 암모늄염의 형성 및 음이온 교환
EP1582204B1 (de) * 1999-03-03 2013-09-25 Eli Lilly & Company Echinocandin pharmazeutische Zusammensetzungen enthaltend Mizellen bildende Tenside
JP2002538097A (ja) 1999-03-03 2002-11-12 イーライ リリー アンド カンパニー 薬学的経口ecb処方物および組成物の作製方法
WO2000052037A1 (en) * 1999-03-03 2000-09-08 Eli Lilly And Company Echinocandin/carbohydrate complexes
TWI232102B (en) 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
US6991800B2 (en) * 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
US9678083B2 (en) * 2009-10-14 2017-06-13 Dana-Farber Cancer Institute, Inc. Protected amine labels and use in detecting analytes
PL243656B1 (pl) * 2018-05-30 2023-09-25 Boruta Zachem Biochemia Spolka Z Ograniczona Odpowiedzialnoscia Sposób usuwania lipopeptydów z roztworów i zmiana ich struktury
AR122707A1 (es) * 2020-06-23 2022-09-28 Genentech Inc Compuestos macrocíclicos y métodos de uso de los mismos

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320052A (en) 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293489A (en) 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US5166135A (en) 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
DK173802B1 (da) 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
CA2037957A1 (en) 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
GB2241956A (en) 1990-03-16 1991-09-18 Merck & Co Inc N-acylated cyclohexapeptide compounds
IL97347A0 (en) 1990-03-19 1992-05-25 Merck & Co Inc Lipopeptide derivatives and antimicrobial compositions containing them
US5330973A (en) 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
US5310726A (en) 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
US5386009A (en) 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US5049546A (en) 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
IL98506A (en) 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Cyclic peptide antibiotics processes for the preparation thereof and pharmaceutical compositions containing them
US5337405A (en) 1990-10-02 1994-08-09 Hewlett-Packard Company Guided data presentation
US5369093A (en) 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US5233023A (en) 1991-07-30 1993-08-03 Merck & Co., Inc. Process for phosphate ester compounds of certain cyclohexapeptides
IL122315A (en) 1992-03-19 2002-03-10 Lilly Co Eli Cyclic peptides and antifungal pharmaceutical compositions containing them
US5965525A (en) 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US5541160A (en) 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5646111A (en) 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
CA2217859A1 (en) 1995-05-10 1996-11-14 David Alan Owen Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
US5618787A (en) 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5652213A (en) 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5629290A (en) 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5629289A (en) 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
AU1851797A (en) 1996-02-01 1997-08-22 Eli Lilly And Company Cyclic peptide antifungal agents
US5696084A (en) 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
WO1999006062A1 (en) 1997-08-04 1999-02-11 Eli Lilly And Company Cyclic peptide antifungal agents
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
EP1107981B1 (de) * 1998-08-20 2005-01-26 Eli Lilly & Company Verfahren zur herstellung von ring-modifizierten zyklischen peptidanalogen
EP1107982B1 (de) 1998-08-28 2004-05-19 Eli Lilly & Company Reversible borkomplexe von 1,2-(cis)-diol zyklischen peptiden
JP2002535248A (ja) 1998-12-16 2002-10-22 イーライ リリー アンド カンパニー 環式ペプチド抗真菌剤
JP2002532513A (ja) 1998-12-16 2002-10-02 イーライ リリー アンド カンパニー 糖置換基を有する環式ペプチド抗真菌剤

Also Published As

Publication number Publication date
AU765660B2 (en) 2003-09-25
ES2233070T3 (es) 2005-06-01
US6653281B1 (en) 2003-11-25
US6939946B2 (en) 2005-09-06
WO2000011023A3 (en) 2000-06-15
CA2340676A1 (en) 2000-03-02
DE69923460T2 (de) 2007-01-11
EP1107981A2 (de) 2001-06-20
ATE287899T1 (de) 2005-02-15
US20040068094A1 (en) 2004-04-08
PT1107981E (pt) 2005-05-31
WO2000011023A2 (en) 2000-03-02
DE69923460D1 (de) 2005-03-03
AU5572699A (en) 2000-03-14
JP2002528388A (ja) 2002-09-03
EP1107981B1 (de) 2005-01-26

Similar Documents

Publication Publication Date Title
PT1107981E (pt) Sintese de analogos peptidicos ciclicos de anel modificado
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
ATE203025T1 (de) Reverse-turnmimetika und damit zusammenhängendes verfahren
EA199900278A1 (ru) Модифицированные аминокислоты, содержащие эти соединения лекарственные средства и способ их получения
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
TR200201638T2 (tr) Yeni imidazo[1,3,5]triazinonlar ve kullanımları
ATE266030T1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DK0703788T3 (da) Stabiliseret phenylalaninammoniaklyase
ATE245435T1 (de) Totalsynthese des amino hip analogen von didemnin a
DK0775160T3 (da) Cycliske hexapeptidsomatostatin-analoger
HUP9900935A2 (hu) Baktériumellenes és gombaellenes hatású peptid és eljárás az előállítására
UA42819C2 (uk) Ін`єкційний та інфузійний розчин, що містить енрофлокcацин
ATE228535T1 (de) Zyklische hexapeptide mit fungizider aktivität
ES2180699T3 (es) Agentes antifungicos peptidicos ciclicos.
EA199800034A1 (ru) Способ получения n-монозамещенных и n,n'-дизамещенных асимметричных циклических мочевин
DE69319733D1 (de) In der konformation beschränkte peptid analoge als wirkstoff gegen plättchenaggregation
DE69623635D1 (de) Mu-opioidligande: agonisten und antagonisten
NO981340L (no) Stabiliserte fosfolipidsammensetninger
SE9800865D0 (sv) New Process
FR2766489B1 (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent
NO962620L (no) Nye mellomprodukter for syntese av L-aspartyl-D--aminoalkanoyl-(S)-N--alkylbenzylamider anvendbare son kunstige sötningsmidler
NZ506667A (en) A process for the conversion of echinocandin class of peptides to their c4-homotyrosine monodeoxy analogues
PT946538E (pt) Derivados de indano ou de di-hidroindole
NO20014937D0 (no) Naturlige pseudomycinprodukter
RU94017615A (ru) Способ получения пептида